These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 9351645)
1. Block of LTP in rat hippocampus in vivo by beta-amyloid precursor protein fragments. Cullen WK; Suh YH; Anwyl R; Rowan MJ Neuroreport; 1997 Oct; 8(15):3213-7. PubMed ID: 9351645 [TBL] [Abstract][Full Text] [Related]
2. Use-dependent effects of amyloidogenic fragments of (beta)-amyloid precursor protein on synaptic plasticity in rat hippocampus in vivo. Kim JH; Anwyl R; Suh YH; Djamgoz MB; Rowan MJ J Neurosci; 2001 Feb; 21(4):1327-33. PubMed ID: 11160403 [TBL] [Abstract][Full Text] [Related]
3. Blockade of long-term potentiation by beta-amyloid peptides in the CA1 region of the rat hippocampus in vivo. Freir DB; Holscher C; Herron CE J Neurophysiol; 2001 Feb; 85(2):708-13. PubMed ID: 11160505 [TBL] [Abstract][Full Text] [Related]
4. [Involvement of protein tyrosine kinases in β-amyloid protein-induced suppression of long-term potentiation in the rat hippocampal CA1 region in vivo]. Guo F; Li XY; Wang XH; Qi JS Sheng Li Xue Bao; 2009 Jun; 61(3):263-71. PubMed ID: 19536439 [TBL] [Abstract][Full Text] [Related]
5. GLP-1 agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid. Gault VA; Hölscher C Eur J Pharmacol; 2008 Jun; 587(1-3):112-7. PubMed ID: 18466898 [TBL] [Abstract][Full Text] [Related]
6. Amyloid beta-protein fragment 31-35 suppresses long-term potentiation in hippocampal CA1 region of rats in vivo. Zhang JM; Wu MN; Qi JS; Qiao JT Synapse; 2006 Sep; 60(4):307-13. PubMed ID: 16786537 [TBL] [Abstract][Full Text] [Related]
7. Protein kinase C mediates amyloid beta-protein fragment 31-35-induced suppression of hippocampal late-phase long-term potentiation in vivo. Zhang JF; Qi JS; Qiao JT Neurobiol Learn Mem; 2009 Mar; 91(3):226-34. PubMed ID: 19061963 [TBL] [Abstract][Full Text] [Related]
8. Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo. Jing W; Guo F; Cheng L; Zhang JF; Qi JS Neurosci Lett; 2009 Feb; 450(3):306-10. PubMed ID: 19059464 [TBL] [Abstract][Full Text] [Related]
9. Nicotine enhances the depressive actions of A beta 1-40 on long-term potentiation in the rat hippocampal CA1 region in vivo. Freir DB; Herron CE J Neurophysiol; 2003 Jun; 89(6):2917-22. PubMed ID: 12611941 [TBL] [Abstract][Full Text] [Related]
11. Protease-resistant glucose-dependent insulinotropic polypeptide agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid. Gault VA; Hölscher C J Neurophysiol; 2008 Apr; 99(4):1590-5. PubMed ID: 18234983 [TBL] [Abstract][Full Text] [Related]
12. The role of c-Jun N-terminal kinase in the A beta-mediated impairment of LTP and regulation of synaptic transmission in the hippocampus. Costello DA; Herron CE Neuropharmacology; 2004 Apr; 46(5):655-62. PubMed ID: 14996543 [TBL] [Abstract][Full Text] [Related]
13. Alpha4beta2 nicotinic acetylcholine receptors are required for the amyloid beta protein-induced suppression of long-term potentiation in rat hippocampal CA1 region in vivo. Wu MN; He YX; Guo F; Qi JS Brain Res Bull; 2008 Sep; 77(2-3):84-90. PubMed ID: 18602971 [TBL] [Abstract][Full Text] [Related]
14. Effects of intrahippocampal CT105, a carboxyl terminal fragment of beta-amyloid precursor protein, alone/with inflammatory cytokines on working memory in rats. Matsumoto Y; Watanabe S; Suh YH; Yamamoto T J Neurochem; 2002 Jul; 82(2):234-9. PubMed ID: 12124424 [TBL] [Abstract][Full Text] [Related]
15. Interaction of Isoflurane, Tumor Necrosis Factor-α and β-Amyloid on Long-term Potentiation in Rat Hippocampal Slices. Zhou R; Bickler P Anesth Analg; 2017 Feb; 124(2):582-587. PubMed ID: 28099324 [TBL] [Abstract][Full Text] [Related]
16. A beta 25-35-induced depression of long-term potentiation in area CA1 in vivo and in vitro is attenuated by verapamil. Freir DB; Costello DA; Herron CE J Neurophysiol; 2003 Jun; 89(6):3061-9. PubMed ID: 12611943 [TBL] [Abstract][Full Text] [Related]
17. Probiotic treatment improves the impaired spatial cognitive performance and restores synaptic plasticity in an animal model of Alzheimer's disease. Rezaei Asl Z; Sepehri G; Salami M Behav Brain Res; 2019 Dec; 376():112183. PubMed ID: 31472194 [TBL] [Abstract][Full Text] [Related]
18. Val8-glucagon-like peptide-1 protects against Aβ1-40-induced impairment of hippocampal late-phase long-term potentiation and spatial learning in rats. Wang XH; Li L; Hölscher C; Pan YF; Chen XR; Qi JS Neuroscience; 2010 Nov; 170(4):1239-48. PubMed ID: 20727946 [TBL] [Abstract][Full Text] [Related]
19. Alzheimer amyloid beta-peptide A-beta25-35 blocks adenylate cyclase-mediated forms of hippocampal long-term potentiation. Bisel BE; Henkins KM; Parfitt KD Ann N Y Acad Sci; 2007 Feb; 1097():58-63. PubMed ID: 17413011 [TBL] [Abstract][Full Text] [Related]
20. Activation of α7 nicotinic acetylcholine receptors persistently enhances hippocampal synaptic transmission and prevents Aß-mediated inhibition of LTP in the rat hippocampus. Ondrejcak T; Wang Q; Kew JN; Virley DJ; Upton N; Anwyl R; Rowan MJ Eur J Pharmacol; 2012 Feb; 677(1-3):63-70. PubMed ID: 22200627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]